FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Purpose - - Integrated genomics approaches have revealed at least four distinct biologic variants of medulloblastoma: WNT (wingless), SHH (sonic hedgehog), group C, and group D. Because of the remarkable clinical heterogeneity of group D tumors and the dismal prognosis of group C patients, it is vi...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 12, 2011
|
| In: |
Journal of clinical oncology
Year: 2011, Volume: 29, Issue: 29, Pages: 3852-3861 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2011.36.2798 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2011.36.2798 Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2011.36.2798 |
| Author Notes: | Marc Remke, Thomas Hielscher, Andrey Korshunov, Paul A. Northcott, Sebastian Bender, Marcel Kool, Frank Westermann, Axel Benner, Huriye Cin, Marina Ryzhova, Dominik Sturm, Hendrik Witt, Daniel Haag, Grischa Toedt, Andrea Wittmann, Anna Schöttler, André O. von Bueren, Andreas von Deimling, Stefan Rutkowski, Wolfram Scheurlen, Andreas E. Kulozik, Michael D. Taylor, Peter Lichter, and Stefan M. Pfister |
Search Result 1
Search Result 2